Which benzodiazepines can be administered intravenously (IV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Midazolam, diazepam, lorazepam, and clonazepam can be administered intravenously, but midazolam is the most commonly used due to its rapid onset and short duration of action. When considering the administration of benzodiazepines intravenously, it's crucial to weigh the benefits against the potential risks, including respiratory depression, hypotension, and paradoxical reactions 1. The choice of benzodiazepine for intravenous administration depends on the specific clinical scenario, including the procedure, patient characteristics, and the desired onset and duration of action.

Key Characteristics of Intravenous Benzodiazepines

  • Midazolam: Rapid onset (1-5 minutes), short duration of action (30-60 minutes), commonly used for procedural sedation 1.
  • Diazepam: Slower onset (2-5 minutes) but longer duration (15-60 minutes), used less frequently than midazolam for endoscopic sedation 1.
  • Lorazepam: Moderate onset (5-20 minutes) with extended duration (6-8 hours), useful for status epilepticus 1.
  • Clonazepam: Can be given IV but is less commonly used this way.

Considerations for Administration

When administering IV benzodiazepines, careful monitoring is essential due to the risk of respiratory depression, hypotension, and paradoxical reactions 1. Flumazenil should be available as an antidote for overdose situations. The IV route provides a rapid therapeutic effect, making it valuable in emergency situations such as acute seizures, severe anxiety, and pre-procedural sedation where quick onset is crucial.

Clinical Guidelines and Recommendations

The most recent and highest quality study 1 provides a comprehensive overview of the clinical pharmacology of sedative medications, including benzodiazepines, highlighting their onset, elimination half-life, active metabolites, loading doses, maintenance dosing, and adverse effects. This information is critical for guiding the selection and administration of benzodiazepines in clinical practice, prioritizing patient safety and effective sedation.

From the FDA Drug Label

The usual recommended dose of lorazepam injection is 4 mg given slowly (2 mg/min) for patients 18 years and older. The usual recommended initial dose of lorazepam for intravenous injection is 2 mg total, or 0.02 mg/lb (0.044 mg/kg), whichever is smaller. Midazolam is approximately 97% bound to plasma protein, principally albumin and that for 1-hydroxy metabolite is about 89%. In adults and pediatric patients older than 1 year, midazolam is administered intravenously

Benzodiazepines that can be given intravenously:

  • Midazolam 2
  • Lorazepam 3

From the Research

Benzodiazepines for Intravenous Administration

The following benzodiazepines can be given intravenously:

  • Midazolam: It is a short-acting water-soluble benzodiazepine that can be administered intravenously for sedation, induction, and maintenance of anesthesia 4, 5, 6.
  • Diazepam: Although it is lipid-soluble and highly protein-bound, diazepam can be administered intravenously for the management of status epilepticus, but its effective duration of action is limited to 20-30 minutes 4, 7.
  • Lorazepam: It can be administered intravenously for sedation, induction, and maintenance of anesthesia, as well as for the management of status epilepticus, with a longer duration of action compared to diazepam 4, 7.

Key Considerations

When administering benzodiazepines intravenously, it is essential to consider their pharmacokinetic properties, such as metabolism, elimination, and potential interactions with other drugs 4, 5, 6. Additionally, the risk of dependence and withdrawal symptoms should be carefully evaluated, especially with long-term use 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.